View Older Stories View More Recent Stories
-
Roth Capital Starts U.S. Geothermal (HTM) at Buy
-
Roth Affirms Cytori Therapeutics (CYTX) at 'Buy' Following Phase III STAR Trial Enrollment Milestone
-
Roth Remains Positive on Aduro Biotech (ADRO) Upon Start of SEASCAPE Trial; Affirms at 'Buy'
-
Quest Resource Holding (QRHC) Prices Common Stock, Warrants Offering for Proceeds of $3.34M
-
Quest Resource Holding Corporation Prices $3.34 Million Underwritten Public Offering
-
Quest Resource Holding Corporation Announces Proposed Underwritten Public Offering
-
Heat Biologics Announces Closing of Public Offering
-
Celator Pharmaceuticals (CPXX) Prices 4M Common Stock Offering at $9.50/Share
-
Celator® Pharmaceuticals Announces Pricing Of A $38.0 Million Public Offering Of Common Stock
-
Celator Pharmaceuticals (CPXX) Plans Common Stock Offering
-
Celator® Pharmaceuticals Announces Proposed Public Offering Of Common Stock
-
Notable Analyst Rating Changes 3/22: (WYNN) (AIG) (PBR) Upgraded; (EPE) (CPA) (INFI) Downgraded
-
Roth Positive on BioLineRx (BLRX) Ahead of Phase 2a AML Data; Reaffirms at 'Buy'
-
Roth Capital Starts RadiSys (RSYS) at Buy
-
Ironclad Performance Wear Corporation Announces Hiring Of Roth Capital Partners To Explore Growth Opportunities
-
Roth Remains Positive on Aduro Biotech's (ADRO) CRS-207 ECLIPSE Outcome; Reaffirms at 'Focus Pick'
-
NDA, MAA Remain Key Focal Points for Celator Pharma (CPXX) Moving Forward; Roth Affirms at 'Buy'
-
Heat Biologics (HTBX) Prices 9.1M Common Stock, Warrants Offering at $0.75/Unit
-
Heat Biologics Announces Public Offering of Common Stock and Warrants
-
Pre-Open Stock Movers 03/17: (VTAE) (RSTI) (AQXP) Higher; (SXE) (ORPN) (SALT) Lower (more...)
-
Roth Capital Starts Zynerba Pharmaceuticals (ZYNE) at Buy
-
BioBlast Pharma (ORPN) Prices Common Stock, Warrants Direct Offering for Proceeds of $6.7M
-
BioBlast Pharma Announces Pricing of $6.7 Million Registered Direct Offering
-
Quicklogic Corp (QUIK) Prices 10M Common Stock Offering at $1/Share
-
QuickLogic Corporation Prices Public Offering of Common Stock
-
Staffing 360 Solutions to Present at the 28th Annual ROTH Conference Today at 7:30 am Pacific
-
Capricor Therapeutics Announces $4 Million Registered Direct Offering
-
Roth Capital Upgrades Outerwall Inc. (OUTR) to Neutral
-
Roth Boosts PT on Celator Pharma (CPXX) to $22 Following Vyxeos Phase III Data in High-Risk sAML
-
Elio Motors to Present at the 28th Annual ROTH Conference on March 15, 2016
-
Teligent, Inc. To Present At Roth Capital Partners 28th Annual Growth Stock Conference On March 14, 2016
-
The Piacente Group Sponsors the ROTH Capital Partners 28th Annual OC Growth Stock Conference for the 11th Consecutive Year
-
Simplifying the M&A Process - Vintage to Lead Document Workflow Discussions at ROTH Capital Partners 28th Annual Conference
-
Energy Fuels Announces Closing of Previously Announced US$12.075 Million Offering of Units
-
IRTH Communications Sponsors the 28th Annual ROTH Capital Conference
-
Ocean Power Technologies (OPTT) Announces Rebranding of PowerBuoy Systems
-
Ocean Power Technologies Rebrands its PowerBuoy® Systems
-
Roth Capital Keeps Plug Power (PLUG) at 'Neutral'; Sees GenCare Momentum Accelerating in 2016
-
Cartesian to Present at the 28th Annual ROTH Conference on March 16, 2016
-
Paramount Gold And Silver (PZG) Agrees to Acquire Calico Resources, Related Assets
-
Paramount Gold Nevada Enters Into an Agreement to Acquire Calico Resources Corp. and its Advanced Stage Grassy Mountain Project
-
Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
-
Plug Power CEO to Present at 28th Annual ROTH Conference
-
CUI Global to Present in New Time Slot at 28th Annual ROTH Conference in Southern California
-
Justin Keener and JMJ Financial Announce Sponsorship of the Annual ROTH Capital Partners Growth Stock Conference March 13-16
-
Soft Health Technologies LLC to Present Its New Technology for Stress Urinary Incontinence, Finess®, at 28th Annual ROTH Conference
-
UTStarcom to Present at the 28th Annual ROTH Conference on March 15, 2016
-
Roth Affirms Revolution Lighting (RVLT) at 'Buy'; Notes Strong Organic Growth Outlook
-
Naia Rare Diseases, Inc. to Present at 28th Annual ROTH Capital Conference on Tuesday, March 15, 2016

